Probi® Sensia is based on L. plantarum HEAL9 (HEAL9™), a unique clinically documented probiotic strain developed by Probi® and protected by patents worldwide. Probi® Sensia impacts the mental processes relating to the input and storage of information and how that information is used to guide a person’s function and behavior. Randomized controlled studies have shown […]
Lactiplantibacillus plantarum HEAL9 (HEAL9™) Read More »
Synbiotics by Probi and Clasado combines the most researched probiotic strains with the most comprehensively studied galactooligosaccharide (GOS) prebiotic available on the market. Bimuno® GOS is supported by over 110 publications, including 20+ clinical trials, while Probi Digestis® and Probi Defendum® boasts over 250 publications, including 80+ clinical trials. These synbiotic concepts represent truly scientifically
Synbiotics by Probi® and Clasado Read More »
Probi Defendum® is based on a combination of the probiotic strains Lactiplantibacillus plantarum HEAL9 (HEAL9™) and Lacticaseibacillus paracasei 8700:2 (L. paracasei 8700:2™), equally contributing to the clinically documented dose of 1 billion (1 B) CFU per day. Several studies describe immune effects after intake of Probi Defendum® with findings on endpoints such as decreased incidence
Probi Digestis® is based on the probiotic strain Lactiplantibacillus plantarum 299v (LP299V®). LP299V® has been documented within several areas, all related to health benefits in the gut. It is described in more than 200 scientific publications and has been subject to more than 70 clinical studies. Clinical results have been shown within areas reaching from
Probi® Osteo is based on a combination of three probiotic strains, Lactiplantibacillus plantarum HEAL9 (HEAL9™), Lactiplantibacillus plantarum HEAL19 and Lacticaseibacillus paracasei 8700:2 (L. paracasei 8700:2™), equally contributing to the clinically documented dose of 10 billion (10 B) CFU per day. Results from studies have shown that the combination of the three strains have an impact
Rebalance of intestinal microbiota • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus acidophilus – LA02 (DSM 21717) Read More »
Wellderly is a probiotic complex by SynBalance, specifically designed for elderly well-being.Based on in-vitro rational and clinical trial, Wellderly provides relief from inflammatory symptoms, improves gastro-intestinal motility, restores healthy microbiota diversity and promotes body natural defenses.A randomized, double blind, placebo control human clinical trial has involved 50 subjects which took the product for 28 days
Under worldwide exclusive license from BIOMAN for nutraceutical and pharma applications Carrier of selenium with high bioavailability • Organic selenium from probiotic strain allergen free with High Bioavailability: Protection of DNA, proteins and lipids from oxidative damage • Normal function of the immune system • Maintenance of normal bone • Normal cognitive function
Lactobacillus reuteri (formerly buchneri) – Lb26 (DSM 16341) Read More »
Probi® Sensia is based on L. plantarum HEAL9 (HEAL9™), a unique clinically documented probiotic strain developed by Probi® and protected by patents worldwide. Probi® Sensia impacts the mental processes relating to the input and storage of information and how that information is used to guide a person’s function and behavior. Randomized controlled studies have shown
Constipation • Intestinal transit • Leaky gut • Inhibition of E. coli• Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production • Cystitis • Inhibition of E. coli • Oxalate degradation • Reduction of intestinal inflammation • Potential reduction of kidney stones incidence
Lactobacillus plantarum – LP01 (LMG P-21021) Read More »
Inhibition of E. coli • Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Lactobacillus rhamnosus – LR06 (DSM 21981) Read More »
Treatment of atopic dermatitis • Improvement of the Quality of Life in subjects with Atopic Dermatitis • Skin health • Inhibition of C. acnes (formerly classified as P. acnes) – induced IL-8 release. Antioxidant activity • Reduced glutathione (GSH) and superoxide dismutase (SOD) production
Lactobacillus salivarius – LS01 (DSM 22775) Read More »
L. plantarum WJL is a second precision probiotic developed by TargEDys in collaboration with the Functional Genomics Institute of Lyon, selected by its ability to optimize the amino acid absorption, by a stimulation of the somatotroic axis. The potenital of this strain is large: from children growth, elderly bones and muscle mass, sport nutrition to
Lactiplantibacillus plantarum WJL Read More »
Lactiplantibacillus plantarum 299v (LP299V®) is the most clinically documented L. plantarum strain in the world. LP299V® has been documented within several areas, all related to health benefits in the gut. It is described in more than 200 scientific publications and has been subject to more than 70 clinical studies. Clinical results have been shown within
Lactiplantibacillus plantarum 299v (LP299V®) (DSM 9843) Read More »
Several studies have shown that Lactiplantibacillus plantarum 6595 (Probi® Plantarum 6595) survives the passage through the GI tract, and attaches to the intestinal cells through a specific mannose-dependent binding mechanism. The bacteria can thereby exert its effects on the intestinal wall, and immune system. Lactiplantibacillus plantarum 6595 (Probi® Plantarum 6595) has also been shown to
Lactiplantibacillus plantarum 6595 (Probi® Plantarum 6595) Read More »
Several studies have shown that Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594) can survive and persist in the gastrointestinal tract in humans. The strain was even recovered in the faeces in nearly all subjects up to 15 days after administration. Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594) has been shown to support the immune system, as well
Lacticaseibacillus rhamnosus 6594 (Probi® Rhamnosus 6594) Read More »
MicrobiomeHUB is a space that brings together the companies of the microbiome industry
Brought to you by Clorofilla Scientific Publishing
This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.
Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963
© ALL RIGHTS RESERVED
